Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Palbociclib is under clinical development by Pfizer and currently in Phase II for Renal Cell Carcinoma.
World Kidney Cancer Day was first observed on June 15, 2017. This is a cancer that begins in your kidneys. There are certain factors that increase an individual’s risk of developing kidney cancer. Read on to know about some of the common risk factors that might lead one to develop the ...
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
LG Chem and AVEO Oncology announced the enrolment of the first subject in Phase I study of LB-LR1109, an anti-cancer investigational drug.
Kidney cancer, a type of urogenital cancer, imposes a high burden on patients. Despite this, no recent research has evaluated the burden of this type of cancer in the Middle East and North Africa (MENA) region. This study explored the burden of kidney cancer from 1990 to 2019 according to age, ...
NPX-267 is under clinical development by NextPoint Therapeutics and currently in Phase I for Renal Cell Carcinoma.
Nivolumab/cabozantinib combination therapy showed consistent benefits across various subgroups in patients with advanced renal cell carcinoma (RCC).
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwestern Medical Centerâs Kidney Cancer Program sheds light
During a Case-Based Roundtable® event, Sumanta Kumar Pal, MD, discussed regimens for recurrent metastatic clear cell renal cell carcinoma including lenvatinib plus everolimus, belzutifan, and investigational cell therapy and bispecific agents in the second article of a 2-part series.
More research is needed to see whether levels of PD-1-expressing tumor macrophages may help identify patients who will respond better to immunotherapy.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.